Heartware International Inc.

HeartWare Reports Additional Clinical Data From Bridge-to-Transplant and Continued Access Patients at the 25th European Association for Cardio-Thoracic Surgery (EACTS) Meeting in Lisbon

HeartWare Completes GLP Studies of Next Generation MVAD Pump; Data Presented Today at ISRBP Congress

FRAMINGHAM, Massachusetts and SYDNEY, October 2, 2011 - Webcast Investor Meeting today at 9:00 a.m.

Older News

LOUISVILLE, Kentucky, September 9, 2011 - - Successful GLP study provides confidence to progress to human clinical trials - Data presented today at the 19th Congress of the International Society for Rotary Blood Pumps (ISRBP) demonstrated that the HeartWare MVAD Pump attained the objectives for system performance, hemocompatability and biocompatibility in Good Laboratory Practice (GLP) animal studies, a significant step prior to commencement of human clinical studies.

MORE..